Integrated Filing — IndAS



General information about company
Scrip Code 526953
NSE Symbol VENUSREM
MSEI Symbol NOTLISTED
ISIN INE411B01019
Name of company VENUS REMEDIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 17-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment PHARMACEUTICALS
Start date and time of board meeting 26-May-2025   16:30:00
End date and time of board meeting 26-May-2025   22:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1949700000 6478900000
Other income 67600000 209600000
Total income 2017300000 6688500000
2 Expenses
(a) Cost of materials consumed 1042100000 3487700000
(b) Purchases of stock-in-trade 21300000 250400000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -32800000 48100000
(d) Employee benefit expense 211600000 804900000
(e) Finance costs 100000 700000
(f) Depreciation, depletion and amortisation expense 47100000 225100000
(f) Other Expenses
1 Selling ,Manufacturing and Administrative expenses 370600000 1071600000
2 Research & Development expenses 46900000 180800000
Total other expenses 417500000 1252400000
Total expenses 1706900000 6069300000
3 Total profit before exceptional items and tax 310400000 619200000
4 Exceptional items 0 99100000
5 Total profit before tax 310400000 718300000
6 Tax expense
7 Current tax 52800000 189300000
8 Deferred tax 18300000 46500000
9 Total tax expenses 71100000 235800000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement -29300000 -29300000
11 Net Profit Loss for the period from continuing operations 210000000 453200000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 210000000 453200000
17 Other comprehensive income net of taxes -8100000 -6800000
18 Total Comprehensive Income for the period 201900000 446400000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 133700000 133700000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 5475800000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 15.71 33.9
Diluted earnings (loss) per share from continuing operations 15.71 33.9
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 15.71 33.9
Diluted earnings (loss) per share from continuing and discontinued operations 15.71 33.9
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1247000000
Capital work-in-progress 263900000
Investment property 0
Goodwill 0
Other intangible assets 0
Intangible assets under development 1047200000
Biological assets other than bearer plants 0
Investments accounted for using equity method 200000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 57000000
Total non-current financial assets 57000000
Deferred tax assets (net)
Other non-current assets 24700000
Total non-current assets 2640000000
2 Current assets
Inventories 1004900000
Current financial asset
Current investments 840900000
Trade receivables, current 1122200000
Cash and cash equivalents 575200000
Bank balance other than cash and cash equivalents 225800000
Loans, current 0
Other current financial assets 8600000
Total current financial assets 2772700000
Current tax assets (net) 108600000
Other current assets 631000000
Total current assets 4517200000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 7157200000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 133700000
Other equity 5475800000
Total equity attributable to owners of parent 5609500000
Non controlling interest
Total equity 5609500000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 0
Provisions, non-current 29000000
Deferred tax liabilities (net) 155800000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 184800000
Current liabilities
Current financial liabilities
Borrowings, current 16900000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 60500000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 858100000
Total Trade payable 918600000
Other current financial liabilities 313800000
Total current financial liabilities 1249300000
Other current liabilities 52800000
Provisions, current 60800000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 1362900000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1547700000
Total equity and liabilites 7157200000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be classified to profit & loss Net of tax -3400000 -4800000
2 Foreign Currency Translation Reserve -1600000 -2500000
Total Amount of items that will not be reclassified to profit and loss -5000000 -7300000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
1 Items that will be classified to profit & loss Net of Tax -3100000 500000
Total Amount of items that will be reclassified to profit and loss -3100000 500000
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -8100000 -6800000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 718300000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories 187400000
Adjustments for decrease (increase) in trade receivables, current 31600000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -45400000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -6000000
Adjustments for other financial assets, current 0
Adjustments for other bank balances -34400000
Adjustments for increase (decrease) in trade payables, current 63000000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 36900000
Adjustments for increase (decrease) in other non-current liabilities -15900000
Adjustments for depreciation and amortisation expense 225100000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 10400000
Adjustments for provisions, non-current -73600000
Adjustments for other financial liabilities, current 104300000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -21100000
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -16300000
Other adjustments to reconcile profit (loss) 10800000
Other adjustments for non-cash items -108500000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 348300000
Net cash flows from (used in) operations 1066600000
Dividends received 0
Interest paid -700000
Interest received -45400000
Income taxes paid (refund) 178500000
Other inflows (outflows) of cash 21100000
Net cash flows from (used in) operating activities 864500000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 16300000
Other cash payments to acquire equity or debt instruments of other entities 649500000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 2000000
Purchase of property, plant and equipment 96300000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 84500000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 45400000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 4100000
Net cash flows from (used in) investing activities -762500000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 9500000
Payments of lease liabilities 0
Dividends paid 0
Interest paid 700000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -10200000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 91800000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents -6200000
Net increase (decrease) in cash and cash equivalents 85600000
Cash and cash equivalents cash flow statement at beginning of period 489600000
Cash and cash equivalents cash flow statement at end of period 575200000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/ S J. K. Jain & Associates Yes 30-Apr-2027